Dyadic International (DYAI) Amortizatization of Intangibles (2018 - 2022)
Dyadic International (DYAI) posted Amortizatization of Intangibles of -$3304.0 for Q4 2022, down 127.82% sequentially from $11877.0 in Q3 2022, and down 104.38% YoY from $75419.0 in Q4 2021.
Dyadic International (DYAI) Amortizatization of Intangibles (2018 - 2022) Analysis & Trends
Dyadic International has reported Amortizatization of Intangibles for 5 years, with the latest figure at -$3304.0 in Q4 2022.
- Quarterly Amortizatization of Intangibles fell 104.38% year-over-year to -$3304.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $33790.0 (down 89.75% YoY) and the FY2022 annual result came in at $33790.0, down 89.75% from the prior year.
- Amortizatization of Intangibles declined to -$3304.0 in Q4 2022 per DYAI's latest filing, from $11877.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $64.0 million in Q1 2021 and troughed at -$63.8 million in Q2 2021.
- A 5-year average of $78476.6 and a median of $67001.5 in 2019 frame the typical range for Amortizatization of Intangibles.
- The widest YoY moves for Amortizatization of Intangibles: up 59524.64% in 2021, down 52105.51% in 2021.
- Over 5 years, Amortizatization of Intangibles stood at $78180.0 in 2018, then retreated by 27.29% to $56846.0 in 2019, then declined by 13.53% to $49154.0 in 2020, then soared by 53.43% to $75419.0 in 2021, then sank by 104.38% to -$3304.0 in 2022.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered -$3304.0, $11877.0, and -$13.4 million for Q4 2022, Q3 2022, and Q2 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Dyadic International | 19.98 Mn | 19.98 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -3,304.00 |
| Dec 31, 2022 | -3,304.00 |
| Sep 30, 2022 | 11,877.00 |
| Sep 30, 2022 | 11,877.00 |
| Jun 30, 2022 | -13.42 Mn |
| Jun 30, 2022 | -13.42 Mn |
| Mar 31, 2022 | 13.45 Mn |
| Mar 31, 2022 | 13.45 Mn |
| Dec 31, 2021 | 75,419.00 |
| Dec 31, 2021 | 75,419.00 |
| Sep 30, 2021 | 94,712.00 |
| Sep 30, 2021 | 94,712.00 |
| Jun 30, 2021 | -63.79 Mn |
| Jun 30, 2021 | -63.79 Mn |
| Mar 31, 2021 | 63.95 Mn |
| Mar 31, 2021 | 63.95 Mn |
| Dec 31, 2020 | 49,154.00 |
| Dec 31, 2020 | 49,154.00 |
| Sep 30, 2020 | 52,204.00 |
| Sep 30, 2020 | 52,204.00 |